“What the Inflation Reduction Act means for PBMs” Times of News This is a strange little article trying to fill a gap in knowledge. The italicized sentences are mine. It does make some sound points on PBMs so I kept it. If you can get into Seeking Alpha or Modern Healthcare, you may find a […]

Inflation Reduction Act The Inflation Reduction Act drug price negotiation is small in returns, low in the number of drugs initially impacted, and slow to start. Ten drugs will be selected and the impact of the act begins in 2026. It rises to 20 drugs to be negotiated in 2029. The new act ignores European […]

“The Justice Department moved on Thursday to block a bankruptcy plan that grants broad legal immunity to the pharmaceutical company Purdue Pharma, whose drug OxyContin has been at the heart of the nation’s opioid epidemic. William K. Harrington, the U.S. trustee for the Justice Department, filed a motion in federal court to halt confirmation of […]

Guest Author at Angry Bear is Professor Joel Eissenberg. Dr. Joel Eissenberg is a professor of Biochemistry and Molecular Biology and is probably a good source to ask questions concerning pandemics and bringing new vaccines to market. Ask questions  .  .   .  I am sure he will answer the same as he has commented in […]

How Pharma Influences Legislation They Do Not Like From 2006 to 2015, pharmaceutical companies spent $880 million in lobbying state and federal legislatures and contributing to campaigns to prevent laws restricting Opioid prescriptions. Their lobbying expenditures has outstripped those advocating for greater controls on prescriptions by 200 times giving them greater influence at the state […]